Current commercial large language models have reached a level where they can generate patentable biotech breakthroughs. The capability is already there.

Here's the paradox: most pharmaceutical scientists still aren't leveraging these tools. They're working with yesterday's playbook while the game is fundamentally changing.

What we're witnessing isn't gradual evolution—it's structural obsolescence creeping across industries. The companies and teams that don't adapt will wake up to find their competitive advantage has evaporated. Pharma, biotech, drug discovery pipelines... the disruption is coming fast.

The tools exist. The knowledge exists. What's missing is the shift in mindset. That gap won't stay open for long.